Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
MIR3652 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
DAPP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SHROOM2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC6A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PLEKHG1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SYNPO2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ENTPD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IFNL3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
NECAP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TBC1D1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ETV6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EHD4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PML - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
APOL2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RBCK1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SAMD9L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRIM38 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CFLAR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DHX58 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on